Literature DB >> 14749395

Mutant MyoD lacking Cdc2 phosphorylation sites delays M-phase entry.

Lionel A J Tintignac1, Valentina Sirri, Marie Pierre Leibovitch, Yann Lécluse, Maria Castedo, Didier Metivier, Guido Kroemer, Serge A Leibovitch.   

Abstract

The transcription factors MyoD and Myf-5 control myoblast identity and differentiation. MyoD and Myf-5 manifest opposite cell cycle-specific expression patterns. Here, we provide evidence that MyoD plays a pivotal role at the G(2)/M transition by controlling the expression of p21(Waf1/Cip1) (p21), which is believed to regulate cyclin B-Cdc2 kinase activity in G(2). In growing myoblasts, MyoD reaccumulates during G(2) concomitantly with p21 before entry into mitosis; MyoD is phosphorylated on Ser5 and Ser200 by cyclin B-Cdc2, resulting in a decrease of its stability and down-regulation of both MyoD and p21. Inducible expression of a nonphosphorylable MyoD A5/A200 enhances the MyoD interaction with the coactivator P/CAF, thereby stimulating the transcriptional activation of a luciferase reporter gene placed under the control of the p21 promoter. MyoD A5/A200 causes sustained p21 expression, which inhibits cyclin B-Cdc2 kinase activity in G(2) and delays M-phase entry. This G(2) arrest is not observed in p21(-/-) cells. These results show that in cycling cells MyoD functions as a transcriptional activator of p21 and that MyoD phosphorylation is required for G(2)/M transition.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14749395      PMCID: PMC344165          DOI: 10.1128/MCB.24.4.1809-1821.2004

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  50 in total

1.  Molecular distinction between specification and differentiation in the myogenic basic helix-loop-helix transcription factor family.

Authors:  D A Bergstrom; S J Tapscott
Journal:  Mol Cell Biol       Date:  2001-04       Impact factor: 4.272

2.  Constitutive instability of muscle regulatory factor Myf5 is distinct from its mitosis-specific disappearance, which requires a D-box-like motif overlapping the basic domain.

Authors:  C Lindon; O Albagli; P Domeyne; D Montarras; C Pinset
Journal:  Mol Cell Biol       Date:  2000-12       Impact factor: 4.272

3.  Promoter-specific regulation of MyoD binding and signal transduction cooperate to pattern gene expression.

Authors:  Donald A Bergstrom; Bennett H Penn; Andrew Strand; Robert L S Perry; Michael A Rudnicki; Stephen J Tapscott
Journal:  Mol Cell       Date:  2002-03       Impact factor: 17.970

Review 4.  Crosstalk between cell cycle regulators and the myogenic factor MyoD in skeletal myoblasts.

Authors:  M Kitzmann; A Fernandez
Journal:  Cell Mol Life Sci       Date:  2001-04       Impact factor: 9.261

5.  The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation.

Authors:  R L Davis; P F Cheng; A B Lassar; H Weintraub
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

6.  Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence.

Authors:  C Murre; P S McCaw; H Vaessin; M Caudy; L Y Jan; Y N Jan; C V Cabrera; J N Buskin; S D Hauschka; A B Lassar
Journal:  Cell       Date:  1989-08-11       Impact factor: 41.582

Review 7.  Regulation of the G2/M transition by p53.

Authors:  W R Taylor; G R Stark
Journal:  Oncogene       Date:  2001-04-05       Impact factor: 9.867

8.  Identification of novel MyoD gene targets in proliferating myogenic stem cells.

Authors:  Jeffrey C Wyzykowski; Therry I Winata; Natalia Mitin; Elizabeth J Taparowsky; Stephen F Konieczny
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

9.  Monoclonal antibodies to mitotic cells.

Authors:  F M Davis; T Y Tsao; S K Fowler; P N Rao
Journal:  Proc Natl Acad Sci U S A       Date:  1983-05       Impact factor: 11.205

10.  Cyclin is degraded by the ubiquitin pathway.

Authors:  M Glotzer; A W Murray; M W Kirschner
Journal:  Nature       Date:  1991-01-10       Impact factor: 49.962

View more
  16 in total

1.  Direct reprogramming of fibroblasts to myocytes via bacterial injection of MyoD protein.

Authors:  Candace Bichsel; Dennis Neeld; Takashi Hamazaki; Lung-Ji Chang; Li-Jun Yang; Naohiro Terada; Shouguang Jin
Journal:  Cell Reprogram       Date:  2013-02-25       Impact factor: 1.987

2.  iPTMnet: an integrated resource for protein post-translational modification network discovery.

Authors:  Hongzhan Huang; Cecilia N Arighi; Karen E Ross; Jia Ren; Gang Li; Sheng-Chih Chen; Qinghua Wang; Julie Cowart; K Vijay-Shanker; Cathy H Wu
Journal:  Nucleic Acids Res       Date:  2018-01-04       Impact factor: 16.971

3.  Conditional transgenic system for mouse aurora a kinase: degradation by the ubiquitin proteasome pathway controls the level of the transgenic protein.

Authors:  Tomokazu Fukuda; Yuji Mishina; Michael P Walker; Richard P DiAugustine
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

4.  Human NDR kinases control G(1)/S cell cycle transition by directly regulating p21 stability.

Authors:  Hauke Cornils; Reto S Kohler; Alexander Hergovich; Brian A Hemmings
Journal:  Mol Cell Biol       Date:  2011-01-24       Impact factor: 4.272

5.  Down-regulation of MyoD by calpain 3 promotes generation of reserve cells in C2C12 myoblasts.

Authors:  Pascal Stuelsatz; Frédéric Pouzoulet; Yann Lamarre; Elise Dargelos; Sylvie Poussard; Serge Leibovitch; Patrick Cottin; Philippe Veschambre
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

6.  Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis.

Authors:  Yuting Sun; Yejing Ge; Jenny Drnevich; Yong Zhao; Mark Band; Jie Chen
Journal:  J Cell Biol       Date:  2010-06-21       Impact factor: 10.539

7.  p38-{gamma}-dependent gene silencing restricts entry into the myogenic differentiation program.

Authors:  Mark A Gillespie; Fabien Le Grand; Anthony Scimè; Shihuan Kuang; Julia von Maltzahn; Vanessa Seale; Ana Cuenda; Jeffrey A Ranish; Michael A Rudnicki
Journal:  J Cell Biol       Date:  2009-12-21       Impact factor: 10.539

8.  Intravital imaging reveals cell cycle-dependent myogenic cell migration during muscle regeneration.

Authors:  Yumi Konagaya; Kanako Takakura; Maina Sogabe; Anjali Bisaria; Chad Liu; Tobias Meyer; Atsuko Sehara-Fujisawa; Michiyuki Matsuda; Kenta Terai
Journal:  Cell Cycle       Date:  2020-11-01       Impact factor: 4.534

9.  Conditional TGF-β1 treatment increases stem cell-like cell population in myoblasts.

Authors:  Xiaodong Mu; Yong Li
Journal:  J Cell Mol Med       Date:  2011-03       Impact factor: 5.310

10.  Inhibition of atrogin-1/MAFbx mediated MyoD proteolysis prevents skeletal muscle atrophy in vivo.

Authors:  Julie Lagirand-Cantaloube; Karen Cornille; Alfredo Csibi; Sabrina Batonnet-Pichon; Marie Pierre Leibovitch; Serge A Leibovitch
Journal:  PLoS One       Date:  2009-03-25       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.